Clinical trial

Obesity Treatment to Improve Diabetes

NCT05390307

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-04-01

PhaseNA

Study timeline

Study start (actual)2023-04-01Date precision: day

Registry last updated2024-02-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

Liraglutide / SemaglutideDRUG

DapagliflozinDRUG · verified · RxNorm: dapagliflozin

Liraglutide or Semaglutide / DapagliflozinDRUG

Liraglutide or Semaglutide / Dapagliflozin plus intensive weight loss nutritionDRUG

Usual careOTHER

Sponsors & collaborators

Dasman Diabetes Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05390307 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.